RedHill Biopharma Submits New Drug Application for Talicia for H. pylori Infection

5 years ago

by David Miller

967 Views

Written by David Miller

TEL-AVIV, Israel and RALEIGH, N.C., May 7, 2019 — RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!